EXICURE, INC. Reclassification from AOCI, Current Period, before Tax, Attributable to Parent
EXICURE, INC. (XCUR) reported Reclassification from AOCI, Current Period, before Tax, Attributable to Parent of $0 for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent · last filed 2023-03-27
- EXICURE, INC. reclassification from aoci, current period, before tax, attributable to parent for the quarter ending 2022-06-30 was $0.00.
- EXICURE, INC. reclassification from aoci, current period, before tax, attributable to parent for the quarter ending 2021-09-30 was $1.00K.
- EXICURE, INC. reclassification from aoci, current period, before tax, attributable to parent for the quarter ending 2021-06-30 was $0.00.
- EXICURE, INC. reclassification from aoci, current period, before tax, attributable to parent for the quarter ending 2020-06-30 was -$3.00K.
- EXICURE, INC. reclassification from aoci, current period, before tax, attributable to parent for fiscal 2021 was $1.00K.
- EXICURE, INC. reclassification from aoci, current period, before tax, attributable to parent for fiscal 2020 was -$3.00K.
| Period end | Reclassification from AOCI, Current Period, before Tax, Attributable to Parent 3 month | Reclassification from AOCI, Current Period, before Tax, Attributable to Parent 6 month | Reclassification from AOCI, Current Period, before Tax, Attributable to Parent 12 month |
|---|---|---|---|
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | ||
| 2021-12-31 | $1.00K 10-K · filed 2023-03-27 | ||
| 2021-09-30 | $1.00K 10-Q · filed 2022-11-14 | $1.00K derived: sum of 2 quarters · filed 2022-11-14 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-15 | ||
| 2020-12-31 | -$3.00K 10-K · filed 2022-03-25 | ||
| 2020-06-30 | -$3.00K 10-Q · filed 2021-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |